BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 16983942)

  • 1. Efficacy and safety of meropenem plus tobramycin followed by meropenem plus vancomycin for treating peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Kobayashi K; Nakamoto H; Okada S; Hoshitani K; Uchida K; Arima H; Shoda J; Takane Y; Ikeda N; Sugahara S; Okada H; Suzuki H
    Adv Perit Dial; 2006; 22():65-8. PubMed ID: 16983942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of vancomycin plus tobramycin as antiperitonitis regimen for patients on CAPD.
    Vargemezis V; Thodis E; Pasadakis P; Martinis G; Kousta E
    Adv Perit Dial; 1990; 6():123-5. PubMed ID: 1982788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
    Mars RL; Moles K; Pope K; Hargrove P
    Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of peritoneal dialysis-associated peritonitis with continuous versus intermittent vancomycin/teicoplanin and ceftazidime in children: preliminary results of a prospective randomized trial. Members of APN Arbeitsgemeinschaft Paidiatrische Nephrologie.
    Klaus G; Schaefer F; Müller-Wiefel D; Mehls O
    Adv Perit Dial; 1995; 11():296-301. PubMed ID: 8534728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial intraperitoneal therapy for CAPD peritonitis: the Network 9 Peritonitis Study.
    Brier ME; Aronoff GR
    Adv Perit Dial; 1994; 10():141-3. PubMed ID: 7999812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefazolin and netilmycin versus vancomycin and ceftazidime in the treatment of CAPD peritonitis.
    Gucek A; Bren AF; Hergouth V; Lindic J
    Adv Perit Dial; 1997; 13():218-20. PubMed ID: 9360685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Our protocol in the treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis].
    Kostić S; Ljuvenović S; Velicković R; Stefanović V; Raicević R; Cukuranović R; Veljković S; Djordjević V; Malobabić Z
    Srp Arh Celok Lek; 1996; 124 Suppl 1():149-51. PubMed ID: 9102884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of peritonitis treated with intraperitoneal (i.p.) weekly vancomycin and i.p. daily netilmicin.
    Chadwick DH; Agarwal S; Vora BJ; Hair M; McKewan A; Gokal R
    J Nephrol; 1999; 12(5):318-21. PubMed ID: 10630696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of intraperitoneal urokinase for resistant bacterial peritonitis in continuous ambulatory peritoneal dialysis.
    Tong MK; Leung KT; Siu YP; Lee KF; Lee HK; Yung CY; Kwan TH; Au TC
    J Nephrol; 2005; 18(2):204-8. PubMed ID: 15931649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Peritonitis in continuous ambulatory peritoneal dialysis. An evaluation of the empiric initial antibiotic treatment].
    Hagelskjaer LH; Møller JK
    Ugeskr Laeger; 1996 Apr; 158(18):2532-7. PubMed ID: 8686006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vancomycin therapy for treatment of peritonitis in outpatients on peritoneal dialysis.
    Yorioka N; Taniguchi Y; Ito T; Katsutani M; Amimoto D; Masaki T; Nishida Y; Kushihata S; Oda H; Yamakido M
    Hiroshima J Med Sci; 1998 Sep; 47(3):105-7. PubMed ID: 9810781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Peritonitis among patients treated with continuous ambulatory peritoneal dialysis].
    Bistrup C; Siboni AH; Pedersen RS
    Ugeskr Laeger; 1995 Jul; 157(28):4023-6. PubMed ID: 7645077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin therapy for gram-positive peritonitis in patients on CAPD.
    Vargemezis V; Pasadakis P; Thodis H; Coucudis P; Peihaberis P; Jafer H; Jara F; Kartali S
    Adv Perit Dial; 1989; 5():128-9. PubMed ID: 2577394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imipenem versus netilmicin and vancomycin in the treatment of CAPD peritonitis.
    Merchant MR; Anwar N; Were A; Uttley L; Tooth JA; Gokal R
    Adv Perit Dial; 1992; 8():234-7. PubMed ID: 1361795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritonitis in continuous ambulatory peritoneal dialysis patients in southern Israel.
    Benjamin J; Ben-Ezer Gradus D; Mostoslavski M; Rapoport J; Chaimovitz C
    Isr J Med Sci; 1989 Dec; 25(12):699-702. PubMed ID: 2613500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment and prevention of relapses of CAPD Pseudomonas peritonitis.
    Pasadakis P; Thodis E; Eftimimiadou A; Panagoutsos S; Papazoglou D; Kaliengidou M; Kartali S; Vargemezis V
    Adv Perit Dial; 1993; 9():206-10. PubMed ID: 8105925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of peritonitis in patients on chronic peritoneal dialysis with a single dose of vancomycin].
    Radovanović Lj
    Srp Arh Celok Lek; 1996; 124 Suppl 1():151-3. PubMed ID: 9102885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin pharmacokinetics during continuous ambulatory peritoneal dialysis in patients with peritonitis.
    Montañés Pauls B; Almiñana MA; Casabó Alós VG
    Eur J Pharm Sci; 2011 Jul; 43(4):212-6. PubMed ID: 21540106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Peritonitis in continuous ambulatory peritoneal dialysis. Culture of peritoneal dialysate fluid].
    Møller JK; Hagelskjaer LH
    Ugeskr Laeger; 1996 Apr; 158(18):2538-41. PubMed ID: 8686007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transperitoneal resorption of cefotiam in CAPD patients with and without peritonitis].
    Thomae U; Koblinger S
    Med Klin (Munich); 1994 Sep; 89(9):464-8. PubMed ID: 7968880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.